These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 30483058)

  • 1. Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders.
    Hughes HK; Mills Ko E; Rose D; Ashwood P
    Front Cell Neurosci; 2018; 12():405. PubMed ID: 30483058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence supporting an altered immune response in ASD.
    Mead J; Ashwood P
    Immunol Lett; 2015 Jan; 163(1):49-55. PubMed ID: 25448709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD).
    Hughes HK; R J Moreno ; Ashwood P
    Brain Behav Immun; 2023 Feb; 108():245-254. PubMed ID: 36494048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Immune Dysfunction and Neuroinflammation in Autism Spectrum Disorder (ASD).
    Hughes HK; Moreno RJ; Ashwood P
    Focus (Am Psychiatr Publ); 2024 Apr; 22(2):229-241. PubMed ID: 38680981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response in autism: a new frontier for autism research.
    Ashwood P; Wills S; Van de Water J
    J Leukoc Biol; 2006 Jul; 80(1):1-15. PubMed ID: 16698940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?
    Gładysz D; Krzywdzińska A; Hozyasz KK
    Mol Neurobiol; 2018 Aug; 55(8):6387-6435. PubMed ID: 29307081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment.
    Ebrahimi Meimand S; Rostam-Abadi Y; Rezaei N
    Expert Rev Clin Immunol; 2021 Jan; 17(1):27-35. PubMed ID: 33191807
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmunity, Autoantibodies, and Autism Spectrum Disorder.
    Edmiston E; Ashwood P; Van de Water J
    Biol Psychiatry; 2017 Mar; 81(5):383-390. PubMed ID: 28340985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of immune dysfunction in the pathophysiology of autism.
    Onore C; Careaga M; Ashwood P
    Brain Behav Immun; 2012 Mar; 26(3):383-92. PubMed ID: 21906670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-emerging concepts of immune dysregulation in autism spectrum disorders.
    Erbescu A; Papuc SM; Budisteanu M; Arghir A; Neagu M
    Front Psychiatry; 2022; 13():1006612. PubMed ID: 36339838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.
    ;
    MMWR Surveill Summ; 2012 Mar; 61(3):1-19. PubMed ID: 22456193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
    Robinson-Agramonte MLA; Noris García E; Fraga Guerra J; Vega Hurtado Y; Antonucci N; Semprún-Hernández N; Schultz S; Siniscalco D
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune dysregulation in autism spectrum disorder.
    Hsiao EY
    Int Rev Neurobiol; 2013; 113():269-302. PubMed ID: 24290389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Gene Expression in Autism Spectrum Disorders: An Extensive Review of Transcriptomic Studies.
    Ansel A; Rosenzweig JP; Zisman PD; Melamed M; Gesundheit B
    Front Neurosci; 2016; 10():601. PubMed ID: 28105001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.
    Melamed IR; Heffron M; Testori A; Lipe K
    Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.
    Ashwood P; Krakowiak P; Hertz-Picciotto I; Hansen R; Pessah I; Van de Water J
    Brain Behav Immun; 2011 Jan; 25(1):40-5. PubMed ID: 20705131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autism spectrum disorders: from immunity to behavior.
    Careaga M; Ashwood P
    Methods Mol Biol; 2012; 934():219-40. PubMed ID: 22933149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune dysfunction and neuroinflammation in autism spectrum disorder.
    Bjorklund G; Saad K; Chirumbolo S; Kern JK; Geier DA; Geier MR; Urbina MA
    Acta Neurobiol Exp (Wars); 2016; 76(4):257-268. PubMed ID: 28094817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.